Seminars in Hematology
Volume 45, Issue 1 , Pages 23-30, January 2008

DNA Methyltransferase and Histone Deacetylase Inhibitors in the Treatment of Myelodysplastic Syndromes

Sidney Kimmel Comprehensive Cancer Centre, Johns Hopkins Hospital, Baltimore, MD.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This work was supported in part by National Cancer Institute Grant No. K24 CA111717.

PII: S0037-1963(07)00164-3

doi:10.1053/j.seminhematol.2007.11.007

Seminars in Hematology
Volume 45, Issue 1 , Pages 23-30, January 2008

Article Tools

* Image Usage & Resolution